Imetelstat Displays Early Efficacy in Myelofibrosis; Phase 3 Trial Is Underway

Related content

• Publications & Research Outputs

• Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis

  Research output: Contribution to journal › Article › peer-review